These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31486103)

  • 1. Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial.
    Seddighnia A; Tadayon Najafabadi B; Ghamari K; Noorbala AA; Ebrahimi Daryani N; Kashani L; Akhondzadeh S
    J Clin Pharm Ther; 2020 Feb; 45(1):97-104. PubMed ID: 31486103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
    Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
    Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.
    Azpiroz F; Dubray C; Bernalier-Donadille A; Cardot JM; Accarino A; Serra J; Wagner A; Respondek F; Dapoigny M
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27477485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
    Jacobsen P; Zhong W; Nomikos G; Clayton A
    J Sex Med; 2019 Oct; 16(10):1638-1649. PubMed ID: 31405765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Mirtazapine on Irritable Bowel Syndrome with Anxiety and Depression: A Case Study.
    Akama F; Mikami K; Watanabe N; Kimoto K; Yamamoto K; Matsumoto H
    J Nippon Med Sch; 2018; 85(6):330-333. PubMed ID: 30568059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
    Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
    Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
    Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
    Faghih Dinevari M; Jafarzadeh F; Jabbaripour Sarmadian A; Abbasian S; Nikniaz Z; Riazi A
    BMC Gastroenterol; 2023 Apr; 23(1):135. PubMed ID: 37098505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.
    Miryan M; Alavinejad P; Abbaspour M; Soleimani D; Ostadrahimi A
    Trials; 2020 Aug; 21(1):698. PubMed ID: 32758282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
    Lu WZ; Gwee KA; Moochhalla S; Ho KY
    Aliment Pharmacol Ther; 2005 Nov; 22(10):927-34. PubMed ID: 16268966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
    Alderson SL; Wright-Hughes A; Ford AC; Farrin A; Hartley S; Fernandez C; Taylor C; Ow PL; Teasdale E; Howdon D; Guthrie E; Foy R; Ridd MJ; Bishop FL; Muir D; Chaddock M; Herbert A; Cooper D; Gibbins R; Newman S; Cook H; Longo R; Everitt H
    Trials; 2022 Jul; 23(1):552. PubMed ID: 35804433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL; Carson RT; Andrae DA
    Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.
    Mahableshwarkar AR; Jacobsen PL; Chen Y
    Curr Med Res Opin; 2013 Mar; 29(3):217-26. PubMed ID: 23252878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surplus vitamin B
    Scholten AM; Vermeulen E; Dhonukshe-Rutten RAM; Verhagen T; Visscher A; Olivier A; Timmer L; Witteman BJM
    Clin Nutr ESPEN; 2018 Feb; 23():48-53. PubMed ID: 29460813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.